PPI-668 tablet

DRUG2 trials

Sponsors

Presidio Pharmaceuticals, Inc.

Conditions

Pharmacokinetic Assessments in Healthy Volunteers

Phase 1

Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations

CompletedNCT01979484

Presidio Pharmaceuticals, Inc.Pharmacokinetic Assessments in Healthy Volunteers

Start: 2013-10-31End: 2013-12-31Updated: 2014-01-09

Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations

CompletedNCT02258321

Presidio Pharmaceuticals, Inc.Pharmacokinetic Assessments in Healthy Volunteers

Start: 2014-10-31End: 2014-12-31Updated: 2015-01-22